G
Genoptix
Provides specialized oncology diagnostics services
About Genoptix
Genoptix, headquartered in Carlsbad, California, specializes in oncology diagnostic testing services. The company primarily serves physicians and patients in the fight against cancer by providing advanced diagnostic tools and expert analysis. Genoptix operates in the healthcare sector, focusing on hematology and oncology diagnostics. The core service offered is flow cytometry, a technique that uses advanced instruments and laser technology to measure properties of cells and detect cancer cells in samples of bone marrow, blood, or lymph nodes. This process involves treating samples with fluorescent antibodies and scanning them with a laser beam to provide accurate diagnoses.
Genoptix boasts one of the largest teams of board-certified experts in one location, ensuring insightful and timely diagnoses for even the most challenging cases. The company operates a laboratory that is open six days a week and offers after-hours assistance through on-duty Client Services Representatives. Genoptix also provides direct billing to established clients such as hospitals and offers a secure web portal for online invoice review and payment. The company simplifies the billing process with a dedicated team of specialists to assist healthcare professionals and patients with insurance coverage, Medicare coding, and payment options. Additionally, Genoptix handles third-party billing for commercial insurance companies, provided that complete and accurate information is submitted on the test requisition form.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Carlsbad, United States
- Employees
- 142
- Open positions
- None listed
- Dealroom signal
- 65.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b, b2c
- Investment activity
- 2 companies, latest Dec 2017
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2011 | $470M | $470M | Novartis | — |
| GROWTH EQUITY VCEquity / VC | Jan 2010 | $0 | — | Hudson River Capital Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Genoptix is 200 monthly website visits, down 57.4% over the last three months. Genoptix's team declined 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Rosetta GenomicsPrinceton, United StatesDiscovering, developing, and commercializing next generation diagnostic tests for personalized medicine
$30Kvaluation
HistoRxNew Haven, United StatesFinding solutions to the complex problems that arise in the biopharmaceutical industry
$24Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Hudson River Capital Partners
Other known investors4 additional known investors
Novartis
University of California, San Diego- CPChicago Growth Partners
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genoptix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genoptix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







